These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18158731)

  • 1. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein.
    McNeal MM; Stone SC; Basu M; Clements JD; Choi AH; Ward RL
    Viral Immunol; 2007 Dec; 20(4):571-84. PubMed ID: 18158731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
    Smiley KL; McNeal MM; Basu M; Choi AH; Clements JD; Ward RL
    J Virol; 2007 Apr; 81(8):3740-8. PubMed ID: 17251301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
    McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
    Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
    VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
    J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).
    McNeal MM; VanCott JL; Choi AH; Basu M; Flint JA; Stone SC; Clements JD; Ward RL
    J Virol; 2002 Jan; 76(2):560-8. PubMed ID: 11752147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
    McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
    Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
    Choi AH; Basu M; McNeal MM; Clements JD; Ward RL
    J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.
    McNeal MM; Basu M; Bean JA; Clements JD; Lycke NY; Ramne A; Löwenadler B; Choi AH; Ward RL
    Vaccine; 2007 Aug; 25(33):6224-31. PubMed ID: 17629371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
    Choi AH; McNeal MM; Flint JA; Basu M; Lycke NY; Clements JD; Bean JA; Davis HL; McCluskie MJ; VanCott JL; Ward RL
    Vaccine; 2002 Mar; 20(13-14):1733-40. PubMed ID: 11906760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G.
    Alkadah A; Thiam F; Mounier M; Charpilienne A; Poncet D; Kohli E; Basset C
    Vaccine; 2013 Apr; 31(15):1924-30. PubMed ID: 23453731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
    Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL
    Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Bacillus subtilis-based rotavirus vaccine.
    Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
    Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4
    Heinimäki S; Malm M; Vesikari T; Blazevic V
    Antiviral Res; 2018 Sep; 157():1-8. PubMed ID: 29935205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.
    Choi AH; Basu M; McNeal MM; Bean JA; Clements JD; Ward RL
    Protein Expr Purif; 2004 Dec; 38(2):205-16. PubMed ID: 15555936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
    Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immune responses and partial protection in mice after skin immunization with rotavirus VP6 protein and the adjuvant LT(R192G).
    Choi AH; Smiley K; Basu M
    Vaccine; 2005 Mar; 23(17-18):2290-3. PubMed ID: 15755613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles.
    McNeal MM; Rae MN; Bean JA; Ward RL
    J Virol; 1999 Sep; 73(9):7565-73. PubMed ID: 10438846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
    Lappalainen S; Tamminen K; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP6: A candidate rotavirus vaccine.
    Ward RL; McNeal MM
    J Infect Dis; 2010 Sep; 202 Suppl():S101-7. PubMed ID: 20684688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.